Prevalence of NMOSD and MS in the indigenous populations of Australia and New Zealand
Broadley, S.A., Bukhari, W., Khalilidehkordi, E., Mason, F., Barnett, M.H., Taylor, B.V., Fabis-Pedrini, M., Kermode, A.G., Subramanian, S. and Waters, P. (2020) Prevalence of NMOSD and MS in the indigenous populations of Australia and New Zealand. Multiple Sclerosis Journal, 26 (9). NP44.
*Subscription may be required
Abstract
Background: Neuromyelitisoptica spectrum disorders (NMOSD) and multiple sclerosis (MS) have differing population frequencies according to ethnic ancestry. There is very little data relating to the prevalence of these conditions in the Indigenous populations of Australia and New Zealand
Objective: We aimedto estimate the prevalence of NMOSD and MS in these Indigenous populations.
Methods: Cases of suspected NMOSD and MS were referred from 23 centres across Australia and New Zealand. The relative frequencies of self-determined ethnic ancestry were calculated for NMOSD, suspected NMOSD and MS. Prevalence rates for NMOSD and MS in populations of European, Asian, Indigenous and African ancestry were calculated.
Results: PatieInitial treatmentnts with NMOSD were more likely to have Asian, Indigenous or Other (mainly African) ancestry. Per 100,000 the prevalence estimate for NMOSD in people with Māori ancestry was 1.50 (95% CI; 0.52 – 2.49) which was similar to those with Asian ancestry 1.57 (95% CI; 1.15 – 1.98). Prevalence in Australian Aboriginal and Torres Strait Islander populations was 0.38 (95% CI; 0.00 – 0.80) per 100,000 and was similar to rates in populations of European ancestry. There were no significant differences in the clinical phenotype of NMOSD in Indigenous compared to the remainder.
Conclusions: The Māori population has a prevalence of NMOSD that is similar to South East Asian countries, reflecting their historical origins. The prevalence of MS in this group is intermediate between those with South East Asian and European ancestry living in New Zealand. Both NMOSD and MS appear to be uncommon in the Indigenous populations of Australia.
Item Type: | Journal Article |
---|---|
Murdoch Affiliation(s): | Institute for Immunology and Infectious Diseases |
Publisher: | Sage Publications |
Other Information: | Poster session 1 @ PACTRIMS 2019 |
URI: | http://researchrepository.murdoch.edu.au/id/eprint/57412 |
![]() |
Item Control Page |